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Abstract: Self-reported hypersensitivity to food is a common condition and many of these 
patients have indications of intestinal immune activation. Dendritic cells (DCs) are recognized 
as the most potent antigen-presenting cells involved in both initiating immune responses and 
maintaining tolerance. The aims of this study were to evaluate the DC populations  with their 
phenotype and T cell stimulatory capacity in patients with food hypersensitivity and to study 
its relationship with atopic disease. Blood samples from 10 patients with self-reported food 
hypersensitivity, divided into atopic and nonatopic subgroups, and 10 gender- and age-matched 
healthy controls were analyzed by flow cytometry using the Miltenyi Blood Dendritic cells kit. 
Monocyte-derived DCs (moDCs) were evaluated concerning their phenotype and T cell stimula-
tory capacity. DC populations and cell surface markers were not significantly different between 
patients and healthy controls, but moDCs from atopic patients expressed significantly more CD38 
compared to moDCs from nonatopic patients. Moreover, lipopolysaccharide stimulated moDCs 
from atopic patients produced significantly more interleukin-10 compared to nonatopic patients. 
CD38 expression was correlated to total serum immunoglobulin E levels. These findings support 
the notion of immune activation in some patients with self-reported food hypersensitivity. They 
need to be confirmed in a larger cohort.
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Introduction
Self-reported hypersensitivity to food is common in the general population, but there is 
a big discrepancy between perceived food hypersensitivity (20%) and medically con-
firmed food allergy (3%–5%).1 Food allergy can be immunoglobulin E (IgE)-mediated 
(immediate, type I reactions) or non-IgE-mediated (delayed-type hypersensitivity, 
type III or IV).2 Medically confirmed allergic reactions are usually IgE-mediated, but 
non-IgE-mediated (cell-mediated) reactions also exist and are more difficult to   diagnose. 
Gastrointestinal symptoms, especially diarrhea, abdominal pain, and bloating, are 
among the most common complaints attributed to food hypersensitivity. In our previous 
studies, the majority of patients with self-reported food hypersensitivity had irritable 
bowel syndrome (IBS).3 And as in patients with IBS, administration of   low-digestible 
carbohydrates often replicated their gastrointestinal symptoms.4 However, the underly-
ing pathophysiological mechanisms of the IBS-like complaints in patients with food 
hypersensitivity are unknown so far, and there are no current standard diagnostic 
methods available for diagnosing non-IgE-mediated delayed-type hypersensitivity 
reactions, which remain as a possible cause in many of the patients.5International Journal of General Medicine 2011:4 submit your manuscript | www.dovepress.com
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The mucosa of the gastrointestinal tract is constantly in 
  contact with food proteins and bacteria. Dietary protein anti-
gens interact with specific antigen-presenting cells (APCs), 
which help to activate regulatory T cells, usually resulting in 
a suppression of immune responses.6 Dendritic cells (DCs) 
are recognized as the most potent APCs with the unique 
ability to initiate and maintain primary immune responses.7 
DCs acquire antigens in the periphery and migrate to the 
lymph nodes where antigen-specific T lymphocytes recog-
nize the presented peptide antigens and mount an immune 
response.7,8 Moreover, DCs are pivotal in inducing tolerance. 
Initially it was thought that this was restricted to immature 
DC that present self-antigens in the absence of an additional 
stimulus to circulating naïve T cells in peripheral lymphoid 
organs. In the case of autoreactivity, this will normally lead 
to anergy or deletion of auto-reactive T cells, thereby induc-
ing tolerance.9,10 However, this view was challenged when 
it was shown that also DCs with a mature phenotype are 
able to expand regulatory T cells (Tregs).11 Therefore, it has 
been suggested that the main criteria for the direction of the 
immune response – induction of immunity or tolerance – are 
the choice of DC population, maturation status, antigen 
  dosage, and cytokine milieu.12
DCs comprise a heterogeneous cell population which 
can be divided into two main lineages, myeloid DC (mDC), 
also called conventional DC, and plasmacytoid (pDC). The 
latter produces large amounts of type I interferons (INF-α, 
-β, and -ω) in response to viral infections, and are also 
known as natural interferon-producing cells (IPC).13,14 The 
mDC lineage consists of several cell subsets with different 
functions that can be found almost everywhere in the body. 
It is still a matter of debate to what extent cell populations 
characterized in mice correspond to populations identified 
in humans,15 but it is clear that DC subsets have distinct 
functions. In human peripheral blood, mainly three DC 
populations can be   distinguished: pDCs, characterized as 
lin-/HLA-DR+/CD123+/CD303+, type-1 mDC (mDC1; lin-/
HLA-DR+/CD1c+), and type-2 mDC (mDC2; lin-/HLA-DR+/
CD141+).16
In the intestines, DCs are present in the lamina propria 
of the small and large bowel, Peyer’s patches (PPs) and 
mesenteric lymph nodes. DCs have an essential role in 
directing the balance between tolerance and immunity by 
cytokines and expression of costimulatory molecules. In the 
gut, particulate (insoluble) antigens are taken up in two ways: 
i) DCs can directly sample antigens by extending processes 
through the epithelium and into the lumen; and ii) M cells 
which overlie PPs can take up antigens and deliver them 
to subepithelial DCs. However, soluble antigens cross the 
  epithelium through transcellular or paracellular routes, via 
brush border   membrane and tight junctions, respectively.6,17 
After sampling of antigen by DCs, they present them 
as   peptide – major histocompatibility complex (MHC) 
  complexes to effector T-cells in lymphoid organs.
The role of DCs in intestinal food hypersensitivity has not 
been evaluated fully. In the present pilot study, we wanted to 
investigate whether DC populations from patients with self-
reported food hypersensitivity differ from those of healthy 
age- and gender-matched individuals, and their relationship 
with atopic disease. For this purpose, we enumerated the 
DC populations present in peripheral blood and analyzed 
monocyte-derived DCs with regard to their phenotype and 
T cell stimulatory capacity.
Material and methods
Patients
Ten consecutive patients referred to the Haukeland University 
Hospital because of abdominal complaints self-attributed to 
food hypersensitivity were included in the study. Organic 
diseases such as inflammatory bowel diseases (IBD), severe 
anaphylactic reactions, and pregnancy or lactation were 
exclusion criteria.
The patients went through an extensive clinical examina-
tion including both allergological and gastroenterological 
examinations as reported previously.3 Briefly, the allergological 
examination consisted of a full medical history including atopy, 
family history, suspected food items, serum levels of total and 
food-specific IgE, and skin prick tests using a panel of inhalant 
and food antigens (ALK; Abello, Hørsholm, Denmark). The 
serum levels of total and food-specific IgE were analyzed by 
ImmunoCap-System (Phadia, Uppsala, Sweden). Open provo-
cation test and double-blind placebo-controlled food challenge 
test (DBPCFC) were performed by a dietician when indicated 
according to medical history and results of skin prick test and 
food-specific IgE levels in serum. The gastroenterological 
examination included a screening questionnaire based on the 
Rome II criteria for the diagnosis of IBS,18 and gastroscopy 
with gastric and duodenal biopsies to diagnose Helicobacter 
pylori infection and celiac disease, respectively. Stool tests 
were performed to exclude gastrointestinal infections.
The control group consisted of 10 gender- and age-
matched healthy controls without indication of allergic 
disease, including a history of atopy, recruited from the 
same geographical area as the patients. Blood (40–50 mL) International Journal of General Medicine 2011:4 submit your manuscript | www.dovepress.com
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was taken in heparin tubes from all patients and healthy 
controls. At the time of blood taking the patients were neither 
on an elimination diet nor being exposed to food challenge. 
All blood samples were processed within 2 hours.
The study was approved by the Western Norway Regional 
Committee for Medical Research Ethics and the subjects gave 
informed consent for the study.
enumeration of Dc subsets  
in peripheral blood
DC populations were stained with the Blood DC Enumeration 
kit (Miltenyi Biotec, Bergisch Gladbach, Germany), accord-
ing to the manufacturer’s instructions. Cells were analyzed 
on a BD FACSCanto I flow cytometer (BD Bioscience, San 
Jose, CA) and data analyses were performed using FlowJo 
software (Tree Star Inc., Ashland, OR).
ex vivo generation of monocyte-derived 
dendritic cells (moDcs)
DCs were generated from monocytes isolated from hepa-
rinized blood from patients and gender- and age-matched 
healthy controls as described previously.19 Briefly, periph-
eral blood mononuclear cells were separated by density gra-
dient centrifugation and the monocytes were then isolated 
by plastic adherence. The monocytes were cultured with 
interleukin- 4 (IL-4, 20 ng/mL; Immunotools, Friesoythe, 
Germany) and granulocyte macrophage colony-stimulating 
factor (100 ng/mL; Immunotools) in RP10 medium (RPMI 
1640; Cambrex Bioscience, Verviers, Belgium) with 10% 
FCS (PAA, Pasching, Austria); 100 units/mL penicillin and 
100 µg/mL streptomycin (Sigma-Aldrich, St. Louis, MO) 
for 5–6 days to generate immature DC. Cytokines were 
replenished every 2–3 days. In some experiments, matura-
tion of the cells was induced by addition of LPS on day 5 
(100 ng/mL; Sigma-Aldrich, Oslo, Norway) for 24 hours.
Immunostaining
Phenotypic characterization of moDC was performed using 
monoclonal mouse anti-human CD1a-PE (NA1/34-HLK), 
CD14-FITC (UCHM1), HLA-DR-APC (HL-39), CD38-
Alexa Fluor 647 (AT13/5), CD40-FITC (LOB7/6), CD83-PE 
(HB15e), CD86-FITC (BU63) (AbD Serotec, Düsseldorf, 
Germany), CD80-APC (MEM-233; Immunotools), and 
CCR7-PE (R&D systems, Abingdon, UK). The cells were 
incubated with titrated antibodies for 10 minutes at room 
temperature before they were washed and analyzed imme-
diately on a FACSCanto I flow cytometer. All subsequent 
analyses were done using FlowJo software. One percent false-
positive events were accepted throughout the analyses.
Mixed lymphocyte reaction
Responding cells (2 × 105) from allogeneic nonadherent cells 
labeled with CFSE (Vybrant® CFDA SE Cell Tracer Kit; 
Invitrogen, Carlsbad, CA) were co-cultured with various 
numbers of DC (2 × 104 and 5 × 104) in 96-well flat-bottom 
microtiterplates (Greiner Bio-One GmbH, Frickenhausen, 
Germany). CFSE intensity was measured on day 5 using a 
FACSCanto I flow cytometer. All subsequent analyses were 
done using FlowJo software.
cytokine determination
Concentrations of IL-6, IL-10, and IL-12p70 in supernatants 
from moDC cultures were measured with commercially avail-
able two-site sandwich ELISAs from BioLegend (Uithoorn, 
The Netherlands) or R&D Systems (Minneapolis, MN) 
according to the manufacturer’s instructions.
statistical analysis
Statistical analyses were performed by using GraphPad Prism 
5.0 (GraphPad Prism Software Inc., La Jolla, CA). Data are 
presented as percentage of analyzed leukocytes. Values are 
expressed as the median, in some cases with interquartile 
ranges (IQR). A two-tailed Mann–Whitney U test was used 
for comparison of groups. Correlation between total IgE and 
CD38 expression in patients was analyzed using Spearman’s 
rank correlation test.
Results
subjects characteristics
Patients (six female, four male, age range 19–54 years, mean 
age 31 years) and controls (five female, five male, age range 
20–57 years, mean age 34 years) were comparable with 
respect to age and gender.
In the patients, cow’s milk (60% of the patients) and 
wheat flour (60%) were the most commonly suspected food 
item, and diarrhea (80%) and abdominal pain (80%) were 
the most common gastrointestinal symptoms, followed by 
bloating (50%) and nausea (20%).
The patients were divided into atopic and nonatopic sub-
groups, according to history, specific IgE in serum and skin 
prick tests. Atopic individuals were defined as having at least 
one positive skin prick test and/or elevated levels of specific 
IgE in serum to at least one allergen, as well as personal 
history of at least one of the following atopic symptoms: 
atopic dermatitis, asthma, or rhinoconjunctivitis.20 Five of 10 International Journal of General Medicine 2011:4 submit your manuscript | www.dovepress.com
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patients were classified as having atopic disease. Four of those 
were sensitized to at least one inhalant allergen, as verified by 
skin prick test and/or serum-specific IgE whereas three of the 
atopic patients were sensitized to at least one food allergen. 
Birch (80%) and timothy grass (80%) were the most common 
inhalant allergen, while wheat flour (60%) and peanuts (40%) 
were the most common food allergen. Of the atopic patients, 
four had atopic dermatitis (80%), three had rhinoconjunctivitis 
(60%), and one had asthma (20%). Total serum IgE levels were 
significantly higher in the atopic patients (median, 141 kU/L; 
IQR, 45–554 kU/L) than in the nonatopic patients (median, 
19 kU/L; IQR, 7–32 kU/L; P , 0.008).
DBPCFC was positive in one patient (10% of the whole 
study population), which indicates non-IgE-mediated allergy 
or nonallergic food hypersensitivity. None of the patients 
had IgE-mediated food allergy as confirmed by both skin 
prick test, food-specific IgE levels in serum, and DBPCFC 
with the same food item. Nine of 10 patients (90%) had 
gastrointestinal symptoms consistent with IBS, according 
to the Rome II criteria.
Dendritic cell enumeration  
and phenotyping
Using the Blood DC Enumeration kit (Miltenyi Biotec), 
we could not detect differences in the peripheral blood DC 
populations between patients with food hypersensitivity and 
healthy controls (Figure 1). The subgroups, pDCs, mDC1, 
and mDC2, were similar in patients and in controls.
Concerning the phenotype of moDCs, we analyzed 
DC markers (CD14- and CD1a+), costimulatory molecules 
(CD40, CD80, and CD86), DC maturation markers (CD83 
and MHC class II), and molecules shown to be important 
for migration of DC (CCR7 and CD38) in unstimulated and 
lipopolysaccharide (LPS)-stimulated cells. We could not 
detect any obvious differences of expression levels between 
patients and controls, even if the expression of MHC class II 
and CD83 was slightly increased in both unstimulated and 
LPS-stimulated moDCs of patients (Figure 2).
Dendritic cells in atopic disease
Comparing DC populations in the peripheral blood (pDCs, 
mDC1, and mDC2) for atopic and nonatopic subgroups 
yielded no obvious differences between the subgroups (data 
not shown).
Concerning the phenotype, LPS-stimulated moDCs from 
atopic patients expressed significantly more CD38 compared to 
nonatopic patients analyzed by median fluorescence intensity 
(atopic = 1055, nonatopic = 405; P = 0.03; Figure 3B) even 
though the percentage positive cells was not significantly dif-
ferent (atopic = 99%, nonatopic = 79%; Figure 3A). MHC class 
II and CD83 expression did not differ significantly between 
atopic and nonatopic patients, either analyzed as percentage 
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of positive cells or median fluorescence intensity (Figure 3). 
The same results regarding median fluorescence intensity were 
obtained when gating on marker positive cells only. Interest-
ingly, CD38 expression was significantly correlated to total 
serum IgE levels in patients (r = 0.89, P = 0.001).
Functional analyses
We next analyzed the amount of IL-6, IL-10, and 
IL-12p70 in the supernatants of the moDC cultures. 
As expected, no IL-6 or IL-12p70 were produced from 
immature moDCs. The median level of IL-6 and IL-12p70 
produced from   LPS-stimulated moDCs from patients and 
controls was similar (IL-6: patients 741 pg/mL, controls 
708 pg/mL; IL-12p70: patients 91.26 pg/mL, controls 
109.3 pg/mL; Figures 4A and B). LPS stimulation increased 
IL-10 production in both controls and patients (immature 
patients 47.44 pg/mL, immature controls 34.83 pg/mL, 
LPS–stimulation patients 189.9 pg/mL, LPS–stimulation 
controls 146.6 pg/mL, Figure 4C). When we divided the 
patients into atopic and nonatopic subgroups, we found 
that LPS-stimulated moDCs from atopic patients produced 
significantly more IL-10 compared to cells from nonatopic 
patients (atopic 410.1 pg/mL, nonatopic 129.9 pg/mL; 
P = 0.02; Figure 4D).
Analyzing the T cell stimulatory capacity of the gener-
ated DC populations in an allogeneic MLR, we detected no 
obvious differences between cells from patients and controls, 
either analyzed together or divided into atopic and nonatopic 
(data not shown).
Discussion
A relationship between food intolerance and IBS is well 
recognized. Up to 70% of the IBS patients report adverse 
reactions to one or more food items, and almost 90% of IBS 
patients show evidence of immune activation.21,22 Previous 
immunological studies indicate important functions of T 
and B cells in patients with IBS, but we are unable to find 
information about DCs.23 In the present study, most of the 
patients (90%) had IBS-like gastrointestinal symptoms in 
response to food intake. Recently, we have shown that more 
than 60% of patients with self-reported food hypersensitiv-
ity have indications of atopic disease and abnormally high 
numbers of “IgE-armed” mast cells in their duodenal mucosa 
which was correlated to serum total IgE levels.24 Patients 
with self-reported food hypersensitivity also had increased 
concentration of B cell-activation factor (BAFF) in gut lavage 
fluid and blood,25 indicating intestinal immune activation 
in many of these patients. The driving force is not known. 
BAFF is mainly produced and secreted by myeloid cells such 
as DCs, macrophages, and monocytes. If intestinal allergens 
are involved, intestinal DCs may play a role. We therefore 
analyzed various DC populations in the present study.
A vast number of antigens are encountered by the 
intestine, which needs to distinguish between invading 
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pathogens and other nonself antigens introduced as part of 
an individual’s diet. Some DC populations localized in the 
lamina propria of the small intestine and in mesenteric lymph 
nodes have been shown to be important in inducing Treg and 
nonreactivity in the steady state. In patients with active IBD, 
alterations of DC populations in both peripheral blood and 
intestinal mucosa have been described and an involvement 
of DCs in the imbalance between Treg and Th17 cells has 
been proposed.26,27 Furthermore, peripheral blood DCs from 
IBD patients expressed more costimulatory molecules28 and 
displayed aberrant response upon LPS stimulation.29 In the 
present pilot study, patients with self-reported food hypersen-
sitivity had normal DC populations in peripheral blood and 
the phenotype of moDCs was similar in patients and healthy 
controls. However, atopic and nonatopic patients showed 
significantly different CD38 expression on LPS-stimulated 
moDCs. The multifunctional surface marker CD38 is a recep-
tor with ectoenzymatic activity. It catalyzes the production 
of adenosine diphosphate (ADP)-ribose (ADPR) and cyclic 
ADPR from NAD+ resulting in calcium influx. In animal 
models, CD38-deficient mice are defective in mounting 
innate and adaptive immune responses and have impaired 
migration of neutrophils, monocytes, and DCs.30,31 In addi-
tion, these mice exhibit strongly reduced allergen-induced 
airway hyperresponsiveness, which is accompanied by a 
decrease in hallmarks of pulmonary inflammation, as well 
as Th2 cytokine levels (IL-4, IL-5, and IL-13). Concerning 
CD38 expression on moDCs, Fedele and colleagues showed 
that CD38 is highly expressed on monocytes, downregulated 
during DC development, and upregulated upon maturation 
of moDCs.32 Moreover, CD38 has been shown to be impor-
tant for migration, survival, and Th1 immune responses of 
mature moDCs.33 However, not much is known about the 
consequences of CD38 overexpression on DCs.
DCs play an important role in allergic airway disease. 
Increased numbers of airway mucosal DCs are found in 
both allergic rhinitis and asthma, and these DCs express 
the high affinity IgE receptor. Treatment of asthma patients 
with inhaled steroids predictably leads to a decrease in 
airway DC numbers. Another work showed a rapid disap-
pearance of myeloid DC precursors from the circulation, 
but recruitment of these cells into the airway mucosa 
after short-term allergen inhalation.34 Recruitment of DCs 
within the intestinal mucosa during inflammation was also 
shown in patients with IBD.35,36 Therefore, mucosal DC 
characteristics in response to food challenge should be 
investigated in future studies in patients with self-reported 
food hypersensitivity.
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In conclusion, even though only a limited number of 
patients were included in the present pilot study, atopic 
patients had significantly higher CD38 expression on 
LPS-stimulated moDCs compared to nonatopic patients. 
Moreover, LPS stimulated moDCs from atopic patients 
produced significantly more IL-10 compared to nonatopic 
patients. This is an interesting finding as it has been shown 
previously that in inflammatory conditions, IL-10 is 
responsible for the expression of Foxp3 in Tregs.37 It is still 
a matter of debate, however, whether an increase in IL-10 
leads to an increase in IgE production.38 Interestingly, 
CD38 expression was   correlated to total serum IgE levels 
in patients. These findings support the notion of immune 
activation in some patients with self-reported food 
hypersensitivity. Further studies including DC populations 
in the intestinal mucosa and in response to food challenge 
are warranted.
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patients or healthy controls. cytokine production was analyzed by eLIsA. A) IL-12p70 production from LPS-stimulated moDCs from patients (P mat, filled square; n = 9) and 
controls (c mat, open square; n = 9) did not differ significantly. B) No difference in IL-6 production from LPs-stimulated moDcs from patients (P mat, filled square; n = 9) and 
controls (C mat, open square; n = 9) was observed. C) Immature moDCs from patients (P im, filled circle; n = 10) and controls (c im, open circle; n = 10) produce similar 
amounts of IL-10. LPS stimulation (mat) increased IL-10 production in both patients (filled square; n = 9) and controls (open square; n = 9). D) Immature moDcs from atopic 
(filled triangle; n = 5) and nonatopic patients (open triangle; n = 5) secreted similar amounts of IL-10 as cells from controls (open circle; n = 10). LPs-stimulated moDcs from 
atopic patients (filled diamond; n = 4) secreted significantly more IL-10 than LPS-stimulated moDCs from nonatopic patients (open diamond; n = 5).
Abbreviations: IL, interleukin; LPs, lipopolysaccharide; moDcs, monocyte-derived dendritic cells.International Journal of General Medicine
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